These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


433 related items for PubMed ID: 28143439

  • 1. Human papillomavirus infections among women with cervical lesions and cervical cancer in Eastern China: genotype-specific prevalence and attribution.
    Zhang L, Bi Q, Deng H, Xu J, Chen J, Zhang M, Mu X.
    BMC Infect Dis; 2017 Jan 31; 17(1):107. PubMed ID: 28143439
    [Abstract] [Full Text] [Related]

  • 2. Attribution of human papillomavirus types to cervical intraepithelial neoplasia and invasive cancers in Southern China.
    Chan PK, Cheung TH, Li WH, Yu MY, Chan MY, Yim SF, Ho WC, Yeung AC, Ho KM, Ng HK.
    Int J Cancer; 2012 Aug 01; 131(3):692-705. PubMed ID: 21976212
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis.
    Zhang J, Cheng K, Wang Z.
    Arch Gynecol Obstet; 2020 Dec 01; 302(6):1329-1337. PubMed ID: 32914222
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial.
    Monsonego J, Cox JT, Behrens C, Sandri M, Franco EL, Yap PS, Huh W.
    Gynecol Oncol; 2015 Apr 01; 137(1):47-54. PubMed ID: 25667973
    [Abstract] [Full Text] [Related]

  • 8. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL, Hu SY, Zhang Q, Dong L, Feng RM, Han R, Zhao FH.
    J Gynecol Oncol; 2017 Jul 01; 28(4):e30. PubMed ID: 28541628
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy.
    Carozzi FM, Tornesello ML, Burroni E, Loquercio G, Carillo G, Angeloni C, Scalisi A, Macis R, Chini F, Buonaguro FM, Giorgi Rossi P, HPV Prevalence Italian Working Group.
    Cancer Epidemiol Biomarkers Prev; 2010 Sep 01; 19(9):2389-400. PubMed ID: 20826836
    [Abstract] [Full Text] [Related]

  • 12. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J, Cortiñas P, Loureiro CL, Pujol FH, Medina F, Capote-Negrín L, Bianchi G, García-Barriola V, Ruiz-Benni A, Avilán-Rovira J, Acosta H.
    Cancer Epidemiol; 2012 Oct 01; 36(5):e284-7. PubMed ID: 22608058
    [Abstract] [Full Text] [Related]

  • 13. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F, Yan P, Huang X, Wang C, Du H, Qu X, Wu R.
    BMC Cancer; 2022 Jan 06; 22(1):42. PubMed ID: 34991494
    [Abstract] [Full Text] [Related]

  • 14. Distribution of HPV Genotype in Invasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia in Zhejiang Province, Southeast China: Establishing the Baseline for Surveillance.
    Xu XX, Zhou JS, Yuan SH, Yu H, Lou HM.
    Int J Environ Res Public Health; 2015 Sep 02; 12(9):10794-805. PubMed ID: 26404339
    [Abstract] [Full Text] [Related]

  • 15. Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.
    Simonella LM, Lewis H, Smith M, Neal H, Bromhead C, Canfell K.
    BMC Infect Dis; 2013 Mar 03; 13():114. PubMed ID: 23452957
    [Abstract] [Full Text] [Related]

  • 16. Co-infections of HPV16/18 with other high-risk HPV types and the risk of cervical carcinogenesis: A large population-based study.
    Wu P, Xiong H, Yang M, Li L, Wu P, Lazare C, Cao C, Gao P, Meng Y, Zhi W, Lin S, Hu J, Wei J, Ma D, Liu J, Yin P, Xing H.
    Gynecol Oncol; 2019 Dec 03; 155(3):436-443. PubMed ID: 31604662
    [Abstract] [Full Text] [Related]

  • 17. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China.
    Zhang Q, Zhao M, Cao D, Wei X, Wang L, Li Y, Yang T, Zhao J, Pei M, Jia H, Cao S, Quan S, Yang X.
    J Med Virol; 2018 Jan 03; 90(1):165-171. PubMed ID: 28710863
    [Abstract] [Full Text] [Related]

  • 18. The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women.
    Zhao X, Wu Q, Wang X, Fu Y, Zhang X, Tian X, Cheng B, Lu B, Yu X, Lan S, Lu W, Ma D, Cheng X, Xie X.
    Clin Microbiol Infect; 2018 Dec 03; 24(12):1322-1327. PubMed ID: 29518562
    [Abstract] [Full Text] [Related]

  • 19. Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New Zealand.
    Kang YJ, Lewis H, Smith MA, Simonella L, Neal H, Bromhead C, Canfell K.
    BMC Infect Dis; 2015 Aug 22; 15():365. PubMed ID: 26297490
    [Abstract] [Full Text] [Related]

  • 20. Distribution and attribution of high-risk human papillomavirus genotypes in cervical precancerous lesions in China.
    Wang W, An J, Song Y, Wang M, Huang M, Wu L.
    Tumour Biol; 2017 Jul 22; 39(7):. PubMed ID: 28691644
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.